Posted Nov. 11, 2013 at 7:34 a.m.

Premium Lock Exclusive analysis: Gastrointestinal pharma Salix still hungry for more deals

Published: 2013-11-11 07:34:00
Updated: 2013-11-11 07:34:00

Salix Salix Image 1 of 2 · Next Image…

Salix Pharmaceuticals hasn't been shy about M&A to boost growth. But the $2.6 billion acquisition of Santarus brings Salix more than new drugs. In this exclusive story, WRALTechWire providers Insider members with analysis about how this deal helps Salix's drug portfolio....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders